DexCom Inc.

NASDAQ: DXCM · Real-Time Price · USD
80.91
0.95 (1.19%)
At close: Aug 15, 2025, 3:11 PM

DexCom Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
4.03B 3.62B 2.91B 2.45B
Cost of Revenue
1.59B 1.33B 1.03B 768M
Gross Profit
2.44B 2.29B 1.88B 1.68B
Operating Income
600M 597.7M 391.2M 265.8M
Interest Income
134.2M 135M 23.8M 1.7M
Pretax Income
709M 710.4M 390.8M 256.8M
Net Income
576.2M 541.5M 341.2M 216.9M
Selling & General & Admin
1.29B 1.19B 1B 810.5M
Research & Development
552.4M 505.8M 484.2M 604.2M
Other Expenses
n/a n/a 7.5M -1.7M
Operating Expenses
1.84B 1.69B 1.49B 1.41B
Interest Expense
19M 20.3M 18.6M 18.8M
Selling & Marketing Expenses
n/a 180.8M 133M 126.4M
Cost & Expenses
3.43B 3.02B 2.52B 2.18B
Income Tax Expense
132.8M 168.9M 49.6M 39.9M
Shares Outstanding (Basic)
404.63M 386M 389.4M 386.9M
Shares Outstanding (Diluted)
412.7M 425.5M 427.5M 428.8M
EPS (Basic)
1.46 1.44 0.88 0.56
EPS (Diluted)
1.42 1.30 0.80 0.51
EBITDA
945.7M 916.7M 565.3M 377.5M
EBIT
728M 730.7M 409.4M 275.6M
Depreciation & Amortization
217.7M 186M 155.9M 101.9M